RICE HALL JAMES & ASSOCIATES, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1230765
San Diego, CA
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,677,633
+$1,423,699 QoQ
Shares Held
477,416
+2.0% QoQ
Ownership
0.823%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.84316403304456.ToString("F0")%
Shared 0.ToString("F0")%
None 14.156835966955445.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $163,984,394 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
|
521,622 | $30,916,535 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
608,416 | $29,295,230 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
477,416 | $24,677,633 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,230,105 | $21,230,599 | |
| 5 | ALKS |
Alkermes plc.
|
390,344 | $13,802,563 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
99,990 | $13,172,682 | |
| 7 | HROW |
Harrow, Inc.
|
368,177 | $12,981,921 | |
| 8 | EOLS |
Evolus, Inc.
|
1,254,819 | $5,157,306 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,677,633 | 477,416 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,253,934 | 467,886 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,751,910 | 476,081 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $16,536,873 | 524,647 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $16,895,364 | 515,889 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $19,104,955 | 528,345 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $16,861,769 | 540,788 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $13,444,175 | 502,586 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $17,627,127 | 516,773 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $15,336,810 | 529,952 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $15,010,982 | 544,468 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $16,677,077 | 554,793 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $19,973,055 | 551,285 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,091,394 | 619,327 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $22,994,677 | 679,311 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $24,117,891 | 833,952 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $27,631,951 | 854,949 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $24,985,891 | 856,855 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $24,399,876 | 914,881 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $28,414,828 | 922,859 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $27,098,630 | 1,035,089 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $26,100,430 | 1,037,378 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $21,040,355 | 1,009,614 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $21,980,292 | 925,486 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $17,046,514 | 947,555 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||